These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36135343)

  • 1. Stabilizing Mechanisms of β-Lactoglobulin in Amorphous Solid Dispersions of Indomethacin.
    Kabedev A; Zhuo X; Leng D; Foderà V; Zhao M; Larsson P; Bergström CAS; Löbmann K
    Mol Pharm; 2022 Nov; 19(11):3922-3933. PubMed ID: 36135343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of stabilization mechanisms in β-lactoglobulin-based amorphous solid dispersions by experimental and computational approaches.
    Zhuo X; Foderà V; Larsson P; Schaal Z; Bergström CAS; Löbmann K; Kabedev A
    Eur J Pharm Sci; 2024 Jan; 192():106639. PubMed ID: 37967658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Lactoglobulin-based amorphous solid dispersions: A graphical review on the state-of-the-art.
    Zhuo X; Jasiukenaite I; Löbmann K
    Eur J Pharm Biopharm; 2024 Sep; 202():114396. PubMed ID: 38971201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Drug Solubility Enhancement Induced by β-Lactoglobulin-Based Amorphous Solid Dispersions.
    Zhuo X; Sener Z; Kabedev A; Zhao M; Arnous A; Leng D; Foderà V; Löbmann K
    Mol Pharm; 2023 Oct; 20(10):5206-5213. PubMed ID: 37669430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-State NMR Investigation of Drug-Excipient Interactions and Phase Behavior in Indomethacin-Eudragit E Amorphous Solid Dispersions.
    Lubach JW; Hau J
    Pharm Res; 2018 Feb; 35(3):65. PubMed ID: 29464409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the effect of protein secondary structure on the solid state and physical stability of protein-based amorphous solid dispersions.
    Zhuo X; Ochner J; Leng D; Foderà V; Löbmann K
    Eur J Pharm Biopharm; 2024 May; 198():114274. PubMed ID: 38561067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whey proteins as stabilizers in amorphous solid dispersions.
    Mishra J; Bohr A; Rades T; Grohganz H; Löbmann K
    Eur J Pharm Sci; 2019 Feb; 128():144-151. PubMed ID: 30528387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
    Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced dissolution rate of nimodipine through β-lactoglobulin based formulation.
    Leng D; Bulduk B; Anlahr J; Müllers W; Löbmann K
    Int J Pharm; 2023 Mar; 635():122693. PubMed ID: 36754186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot Melt Extrusion and Spray Drying of Co-amorphous Indomethacin-Arginine With Polymers.
    Lenz E; Löbmann K; Rades T; Knop K; Kleinebudde P
    J Pharm Sci; 2017 Jan; 106(1):302-312. PubMed ID: 27817830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
    Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
    Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling.
    Yang Z; Nollenberger K; Albers J; Qi S
    Mol Pharm; 2014 Jul; 11(7):2453-65. PubMed ID: 24897345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
    Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
    Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
    Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX; Anderson BD
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Based Amorphous Solid Dispersion: a Case Study Investigating Different Whey Proteins at High Drug Loading.
    Leng D; Bulduk B; Widmer T; Wiborg O; Sanchez-Felix M; Löbmann K
    Pharm Res; 2023 Jul; 40(7):1865-1872. PubMed ID: 37237165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Drug-Loading Amorphous Solid Dispersions via
    Kapourani A; Andriotis EG; Chachlioutaki K; Kontogiannopoulos KN; Klonos PA; Kyritsis A; Pavlidou E; Bikiaris DN; Fatouros DG; Barmpalexis P
    Mol Pharm; 2021 Dec; 18(12):4393-4414. PubMed ID: 34699238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.